Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities

J Varga, M Trojanowska… - Journal of Scleroderma …, 2017 - journals.sagepub.com
Systemic sclerosis (SSc) is a complex disease characterized by early microvascular
abnormalities, immune dysregulation and chronic inflammation, and subsequent fibrosis of …

The serum vitamin D metabolome: What we know and what is still to discover

RC Tuckey, CYS Cheng, AT Slominski - The Journal of steroid biochemistry …, 2019 - Elsevier
Vitamin D, referring to the two forms, D2 from the diet and D3 primarily derived from
phototransformation in the skin, is a prohormone important in human health. The most …

[HTML][HTML] LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma

C Gur, SY Wang, F Sheban, M Zada, B Li, F Kharouf… - Cell, 2022 - cell.com
Systemic sclerosis (scleroderma, SSc) is an incurable autoimmune disease with high
morbidity and mortality rates. Here, we conducted a population-scale single-cell genomic …

Systemic sclerosis

Y Allanore, R Simms, O Distler… - Nature reviews Disease …, 2015 - nature.com
Systemic sclerosis is a complex autoimmune disease characterized by a chronic and
frequently progressive course and by extensive patient-to-patient variability. Like other …

Cellular interactions in the pathogenesis of interstitial lung diseases

G Bagnato, S Harari - European Respiratory Review, 2015 - Eur Respiratory Soc
Interstitial lung disease (ILD) encompasses a large and diverse group of pathological
conditions that share similar clinical, radiological and pathological manifestations, despite …

Fibrosis—a lethal component of systemic sclerosis

YY Ho, D Lagares, AM Tager, M Kapoor - Nature Reviews …, 2014 - nature.com
Fibrosis is a pathological process characterized by excessive accumulation of connective
tissue components in an organ or tissue. Fibrosis is produced by deregulated wound …

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

D Daoussis, K Melissaropoulos… - Seminars in arthritis and …, 2017 - Elsevier
Objectives Rituximab (RTX) may favorably affect lung function and skin fibrosis in patients
with systemic sclerosis (SSc). We aimed to assess long-term efficacy and safety of RTX in …

The pathogenesis, diagnosis and treatment of Raynaud phenomenon

AL Herrick - Nature Reviews Rheumatology, 2012 - nature.com
The past 10 years have seen the publication of results from several multicentre clinical trials
in primary and systemic sclerosis (SSc)-related Raynaud phenomenon. The publication of …

Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis

N Maugeri, A Capobianco, P Rovere-Querini… - Science translational …, 2018 - science.org
Endothelial cell damage and platelet activation contribute to sustained vasculopathy, which
is a key clinical characteristic of systemic sclerosis (SSc), also known as scleroderma …

[HTML][HTML] CXCL4 drives fibrosis by promoting several key cellular and molecular processes

AJ Affandi, T Carvalheiro, A Ottria, JJ de Haan… - Cell reports, 2022 - cell.com
Fibrosis is a major cause of mortality worldwide, characterized by myofibroblast activation
and excessive extracellular matrix deposition. Systemic sclerosis is a prototypic fibrotic …